의료기기 이야기

Perhaps you have an idea for a medical device that could revolutionize medical care in the US, or perhaps for an improvement that could increase a device's safety or effectiveness. Bringing an innovative device to the U.S. market can present many challenges but also rewards. The US Food and Drug Administration (FDA) wants to encourage improvements to the overall safety and effectiveness of medic..

This guidance document updates and clarifies the information regarding sterilization processes that we recommend sponsors include in 510(k)s for devices labeled as sterile. This guidance document also provides details about the pyrogenicity information that we recommend sponsors include in a 510(k) submission. For the current edition of the FDA-recognized standards referenced in this document, s..

The US Food and Drug Administration (FDA) has begun issuing export documents for medical devices in electronic format in order to help streamline processes and reduce time and effort for manufacturers seeking to sell their products in non-US markets. A letter to industry from FDA explains that the agency’s transition to electronic formats took effect January 2, 2024, and applies to documents suc..

Earlier this month I wrote about the importance of clinical trial transparency and the FDA’s oversight. Today, I’d like to catch up with you about another critical component of FDA’s oversight of clinical studies: our work to harmonize clinical research regulations and to facilitate the development of medical products to benefit public health. Modernizing Clinical Research Oversight Efficient, w..

On November 30, 2023, the FDA announced in the Federal Register its intention to classify certain types of wound dressings that had remained unclassified as pre-amendment devices; i.e., devices that were in commercial distribution before enactment of the Medical Device Amendments of May 28, 1976. The specific wound dressings the FDA is proposing to classify fall into the following three distinct..

한국보건산업진흥원에서 의료기기 제조업체를 대상으로 해외 수출을 지원하고자 세미나를 진행한다. ▶ 날짜: 2023년 12월 13일(수) 10:00 ~ 15:30 ▶ 장소: 한국사회복지회관 대회의실 (서울 마포구 만리재로 14, 르네상스타워 6층) ▶ 선착순 100명 ▶ 중식제공 ▶ 세미나: 의료기기 미국시장 진출 및 FDA 해외펀딩 전략 메드텍 수출지원 협의체 유럽인증 획득 세미나 메드텍 수출지원 협의체 연계 해외시장 진출(미국, 유럽, 호주) 세미나 개최(12.13(수) 10:00~15:30, 한국사회복지회관) 기관별 교육·행사>알림마당-의료기기산업정보 종합정보시스템 (khidi.or.kr) 메드텍 수출지원 협의체 연계 해외시장 진출(미국, 유럽, 호주) 세미나 개최(12.13(수) 10:..

2023년 11월 15일자로 FDA에서 사이버보안과 관련된 내용을 추가 발표하였다 (Updated). [세부내용] November 15, 2023 – The FDA contracted with MITRE to develop the report, Next Steps Toward Managing Legacy Medical Device Cybersecurity RisksExternal Link Disclaimer. Legacy medical devices are those that cannot be reasonably protected against current cybersecurity threats, and these devices can pose significant risks to the health ..

Emergo by UL 에서 미국 US FDA Pre-Submissions에 대한 웨비나를 진행한다. 최근에 FDA에서 변경된 Pre-submission에 대해 설명하고 각 제조업체에서 준비해야 되는 사항에 대해 설명할 것으로 예상된다. ▶ 일자: 2023년 11월 09일(목) 자정 (0시, CST 기준 오전 9시) ▶ 온라인으로 1시간동안 진행 예정 ▶ 링크: U.S. FDA Pre-Submissions | Emergo by UL U.S. FDA Pre-Submissions In this complimentary webinar, our Emergo by UL subject matter expert will outline the latest insights about U.S. FDA Pre-Submiss..

[요약] 코로나때 긴급하게 사용되었던 원격모니터링 장비/기기에 대한 FDA 정책 변화를 가이던스로 발표하였다. FDA is issuing this guidance to provide clarification on its enforcement policies and premarket review expectations for certain non-invasive remote monitoring used for patient monitoring at the conclusion of the COVID-19 public health emergency. FDA believes the policy set forth in this guidance may help FDA and other stakeholders tra..

The FDA Oncology Center of Excellence (OCE) in conjunction with the European Medicines Agency (EMA) will host a Conversations on Cancer public panel discussion October 19, 2023, addressing the experience of living with metastatic breast cancer. The panel will feature speakers with a range of perspectives on breast cancer and, for the first time, will be an international collaboration with our co..